Fierce Healthcare
NOVEMBER 13, 2024
Primary care player Forward is abruptly shutting down its operations, closing its locations and canceling scheduled visits, the company publicly announced Wednesday. | Primary care player Forward is abruptly shutting down its operations, closing its locations and canceling scheduled visits, the company publicly announced Wednesday.
Pharmacy Times
NOVEMBER 13, 2024
There has never been such widespread and popularized use of compounded products due to shortages. Will consumers rise up with pitchforks if the party is shut down?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
NOVEMBER 13, 2024
In the wake of the Covid-19 pandemic, the Food and Drug Administration continues to struggle with a lack of investigators needed to inspect domestic and foreign pharmaceutical manufacturing plants and has not yet developed a plan to keep needed staff, a U.S. government watchdog found. Between November 2021 and this past June, the vacancy rate among investigators increased to 16% from 9%.
Fierce Pharma
NOVEMBER 13, 2024
Lilly unwraps detailed data showing tirzepatide kept nearly 99% of prediabetic patients diabetes-free over 3 years fkansteiner Wed, 11/13/2024 - 14:37
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
NOVEMBER 13, 2024
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning, lots of news this morning that we’ll get straight into.
Fierce Healthcare
NOVEMBER 13, 2024
AUSTIN, Texas—The second annual Fierce Health Payer Summit kicked off Wednesday to tackle the most pressing issues facing health plan leaders. | AUSTIN, Texas—On Day 1 of the Fierce Health Payer Summit, panelists discussed the role of technology to retain members, trends in Medicare Advantage and changes to Medicare Part D.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
NOVEMBER 13, 2024
RSV vaccination is approximately 77% to 81% effective against hospital and emergency department encounters among older adults.
Fierce Healthcare
NOVEMBER 13, 2024
Blue Cross Blue Shield of Massachusetts members will benefit from an expanded partnership with Maven Clinic, a new doula pilot program and more caregiving support in collaboration with Cleo, the co | Blue Cross Blue Shield of Massachusetts is further strengthening its offerings for women through a doula pilot program and more caregiving support.
pharmaphorum
NOVEMBER 13, 2024
AI technology is revolutionising the field of surgery by aiding in more precise and accurate diagnoses. Learn how AI is transforming the future of healthcare.
Pharmacy Times
NOVEMBER 13, 2024
Karyne Jones highlights the importance of pneumococcal vaccination for those 50 years and older, especially in communities of color.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
NOVEMBER 13, 2024
Explore the implications of China's Anti-Espionage Law on pharmaceutical supply chains and learn how businesses can navigate new risks effectively.
Pharmacy Times
NOVEMBER 13, 2024
The designation follows 2 previous orphan drug designations for pancreatic cancer and soft tissue sarcoma.
pharmaphorum
NOVEMBER 13, 2024
London is the top city in Europe for the life sciences industry, and ranks third worldwide after Boston and New York in the US, says MedCity report
Pharmacy Times
NOVEMBER 13, 2024
In the analysis, 34.7% of commercially insured patients with chronic obstructive pulmonary disease or asthma received an influenza vaccination.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
NOVEMBER 13, 2024
BioNTech buys Biotheus and its Keytruda rival for $950m Phil.
Drug Topics
NOVEMBER 13, 2024
Researchers compared the racial and ethnic representation of participants in food allergen trials with patients who experience food allergies.
Pharmaceutical Technology
NOVEMBER 13, 2024
Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics and sterile injectables used in hospitals and clinics, Reuters reported.
Drug Topics
NOVEMBER 13, 2024
A conversation with AJ Loiacono, co-founder and CEO of Capital RX, at NCPA 2024.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Med Ed 101
NOVEMBER 13, 2024
Two tests are commonly used in asthma assessments to monitor symptom control and airflow and this blog post will discuss their use and how they determine appropriate treatment options. Important tests pharmacists should know include the Asthma Control Test and a Peak Expiratory Flow. We will discuss them below. Asthma Control Test The first of two […] The post Two Asthma Assessments That Pharmacists Should Know appeared first on Med Ed 101.
Drug Topics
NOVEMBER 13, 2024
Selina Coleman, JD, Partner in Life Sciences Health Industry Group at Reed Smith LLP, discussed recent developments in Supreme Court decisions impacting pharmacy operations.
Pharmafile
NOVEMBER 13, 2024
Earlier in November, Johnson & Johnson innovative medicine have applied to the US Food and Drug Agency (FDA) and the European Medicines agency (EMA) for the approval of a new indication for DARAZALEX FASPRO (daratumumab and hyluronidase-fihj). DARAZLEX FASPRO would be used as a monotherapy for the treatment of high-risk smoldering multiple myeloma in adult […] The post J&J seek approval for first drug to treat high-risk smoldering myeloma appeared first on Pharmafile.
Drug Topics
NOVEMBER 13, 2024
An FDA representative gave a presentation on her organization’s recent updates regarding drug supply chain rules and regulations.
Fierce Healthcare
NOVEMBER 13, 2024
Papa, a company that offers companion care, has learned valuable lessons in the past seven years as it has expanded its services to more older seniors. | Papa, a company that offers companion care, has learned valuable lessons in the past seven years as it has expanded its services to more older seniors.
STAT
NOVEMBER 13, 2024
U.S. drug overdose deaths are plummeting, putting the country on pace for its first year with fewer than 100,000 overdose deaths since 2020 — a powerful, if bleak, symbolic milestone. Reported drug deaths fell nearly 17% during the 12-month period ending in June, to 93,087, according to new statistics released this week by the Centers for Disease Control and Prevention.
Pharmacy Times
NOVEMBER 13, 2024
White button mushroom can rebuild anti-cancer immune defense while slowing cancer growth.
Outsourcing Pharma
NOVEMBER 13, 2024
Driven by the effects of the COVID-19 pandemic, the market for decentralized clinical trials has seen a push that will lead it to more than triple in size within the next decade.
Pharmacy Times
NOVEMBER 13, 2024
Despite their proven abilities, organizations such as the American Medical Association still oppose so-called “scope creep.
The Checkup by Singlecare
NOVEMBER 13, 2024
FreeStyle Libre is a prescription continuous glucose monitor. It consists of a sensor worn on the skin that monitors tissue glucose levels and a smartphone app or dedicated reader that scans and stores blood glucose level readings. While FreeStyle Libre is used long-term in people, veterinarians use it for a few days to two weeks to manage insulin treatment in dogs.
pharmaphorum
NOVEMBER 13, 2024
Amgen has rebuffed claims made by an analyst suggesting that its obesity drug MariTide is associated with reductions in bone mineral density
The Checkup by Singlecare
NOVEMBER 13, 2024
You might have just started Ozempic (semaglutide), expecting your hunger levels to drop immediately. Yet, you may find yourself just as hungry as you were before. This may be confusing and discouraging, especially after hearing about how other people have experienced a reduced appetite while taking Ozempic. But you may want to remember that Ozempic isn’t approved by the Food and Drug Administration (FDA) for appetite suppression.
Outsourcing Pharma
NOVEMBER 13, 2024
A recent Lindus Health survey emphasizes the importance of patient-centered designs in clinical trials, particularly highlighting how telehealth options could improve accessibility and convenience for participants.
European Pharmaceutical Review
NOVEMBER 13, 2024
New clinical trial findings show that twice-yearly lenacapavir for HIV pre-exposure prophylaxis (PrEP) had high efficacy and safety in a diverse group of participants. This data provides the first in-depth insight into full results of Gilead Sciences pivotal Phase III PURPOSE 2 trial. In the oral PrEP study group, adherence to the small molecule injectable HIV-1 capsid inhibitor and placebo injections was 91.0 percent with on-time injections at week 26, the results showed.
Outsourcing Pharma
NOVEMBER 13, 2024
Driven by the effects of the COVID-19 pandemic, the market for decentralized clinical trials has seen a push that will lead it to more than triple in size within the next decade.
Expert insights. Personalized for you.
145 
Let's personalize your content